Singapore AI Healthtech injewelme Secures $1.2 Million to Scale Contactless Vital Monitoring Technology

Advancing AI Health Monitoring

Singapore-based health technology startup injewelme has secured US$1.2 million in its first institutional funding round. Led by Temasek Trust’s Catalytic Capital for Climate and Health and the Richardson Family, the capital will accelerate the development of its proprietary contactless monitoring software. This funding round was facilitated by the digital marketplace Co-Axis (https://www.coaxis.network), connecting the startup with impact-focused investors.

The startup’s core innovation is DeepHealthVision, a technology that utilizes remote photoplethysmography to measure vital signs. By analyzing a 30-second video of a user's face, the system captures micro-changes in blood flow through standard smartphone or laptop cameras. This allows the AI to extract over 20 different health parameters, including heart rate and blood pressure, without any physical skin contact.

Real-world trials in Singapore have demonstrated detection accuracy levels of 95 percent. This precision enables the software to serve as a reliable screening tool in settings ranging from polyclinics to senior activity centers. For instance, SJ Group has already integrated the technology to reduce senior pre-activity screening times by 50 percent.

With the new capital, injewelme plans to expand its predictive AI models to track more complex data. Upcoming features will include monitoring for blood glucose, hydration levels, and physiological fatigue. This expansion aims to provide a more holistic view of an individual's health through a simple camera lens.

A primary focus of the technological expansion is identifying heat stress and other climate-linked health risks. This allows organizations to monitor the safety of outdoor workers or vulnerable elderly populations during extreme weather events. By transforming common devices into medical-grade monitors, the firm aims to bridge the gap between clinical care and daily health management across Southeast Asia.

James Moon, CEO of injewelme, noted that the financing catalyzes the mission to deliver proactive and data-driven health monitoring at scale. The company (https://www.temasektrust.org.sg) will continue to leverage its strategic partnership with C3H to access broader industry networks and accelerate commercial deployment.